-
Mll3 suppresses tumorigenesis by activating the Ink4a/Arf locus
- Authors
- Soto-Feliciano, Yadira M.Zhu, ChangyuMorris IV, John P.Huang, Chun-Hao13 more author(s)...
- Description
Summary from Dryad: "Abstract: Mutations in genes encoding components of chromatin modifying and remodeling complexes are among the most frequently observed somatic events in human cancers. For example, missense and nonsense mutations targeting the mixed lineage leukemia family member 3 (MLL3/KMT2C) histone methyltransferase occur in a range of solid tumors and heterozygous deletions encompassing...
- Subject
-
Carcinogenesis/geneticsCarcinoma, HepatocellularCyclin-Dependent Kinase Inhibitor p16LeukemiaTumor Suppressor Protein p14ARF
- Access Rights
- Free to All
-
Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Potential Targets for Cancer Immunotherapy
- Authors
- Klatt, Martin GuntherScheinberg, David A.
- Description
Description from PRIDE: "Cyclin dependent kinase 4/6 inhibitors (CDK4/6i) lead to cell-cycle arrest but also trigger T cell-mediated immunity, which might be mediated by the qualitative and quantitative changes in human leukocyte antigen (HLA) ligands on the cancer cell surface. We investigated the effects of CDK4/6i, Abemaciclib and Palbociclib, on the immunopeptidome at subclinical, non-toxic,...
- Subject
-
Breast NeoplasmsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p18HLA AntigensT-Lymphocytes
- Access Rights
- Free to All